美諾華(603538.SH):與默沙東旗下英特威簽訂十年戰略業務合作協議
格隆匯 4 月 22日丨美諾華(603538.SH)公佈,公司於近日與默沙東旗下子公司英特威國際有限公司(INTERVET INTERNATIONAL B.V.,默沙東旗下動物保健公司,又稱MSD Animal Health,“默沙東”)簽訂了《戰略業務合作協議》。
雙方本着平等協商、優勢互補、合作共贏的原則,基於戰略考量並經友好協商,決定在寵物藥、獸藥、動物保健領域共同建立長期穩定的定製研發生產(CDMO)合作伙伴關係。美諾華將依託穩定且高質量的原料藥質量控制體系以及高效可靠的研發技術,為默沙東提供產品相關原料藥的研發、註冊、生產和供應服務,合作期限為十年。
CDMO業務是公司重點推進的新業務,也是未來業績增長的強勁動力。公司致力於依託多年特色原料藥經驗累積形成的質量管理與EHS管理能力、紮實的工藝開發和高標準規模化的生產製造能力,加速打造CDMO一站式綜合服務平台。
此次戰略協議的簽訂標誌着默沙東對公司在原料藥領域研發技術、生產和質量等方面的充分認可,協議的實施將為公司CDMO業務賦能,有利於持續提升公司研發技術能力、項目管理能力,加快CDMO業務戰略佈局,進一步打造公司在CDMO 領域的國際競爭力。此次戰略協議的簽訂對公司經營業績及未來的發展有着積極的影響,符合全體股東的利益和公司長遠發展戰略。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.